Cue Biopharma to raise $50M in oversubscribed private placement
Seeking Alpha ·
Cue Biopharma (CUE) has entered into a definitive securities purchase agreement to raise approximately $50.0M in gross proceeds through a private placement with a group of accredited institutional investors. The financing includes the issuance of 1.42M
DYAX Investor Sentiment
Bullish (Long) 55% · Bearish (Short) 45%
355 participants
Related News
- Billionaire Israel Englander Sells Sandisk Stock and Buys Another AI Memory Stock (Hint: Not Micron)
- Biggest stock movers: WDFC, VOD, and more
- WD-40 surges on Q3 earnings beat
- Sempra appoints CFO Karen Sedgwick as new SoCalGas CEO; Justin Bird to take over as CFO
- Brookdale Senior Living June occupancy reaches 82.5% as demand accelerates
- Polymarket seeks to launch margin trading in U.S. - report